A Virus Targeting Mesothelioma?

Farassati, assistant professor with the University’s Medical School and member of the Cancer Center’s Genetic Mechanisms of Cancer Research Program, received a $100,000 grant in 2007 from the Meso Foundation. Read More

Mesothelioma Clinical Trial

This study "Cisplatin, Pemetrexed, and Imatinib Mesylate in Malignant Mesothelioma" is currently recruiting participants.


Read More about the Clinical Trial here at http://news.mesothelioma--lawfirm.com

A Legal Question:

Will Pennsylvania will adopt the American Law Institute’s Restatement of Torts to recognize elements of negligence in product liability cases?

Mesothelioma Legal Representation

It takes 15 to 60 years for the disease to develop, dating back to the beginning of (or first) exposure. Now, think of this: the disease must be developed before compensation is made. That length of time means that by the time of exposure, the responsible business entity doesn’t even exist any more. This can make getting compensation a tricky thing. With no mesothelioma cure, prognosis is poor and treatment is limited.

Read More

What Questions Regarding Mesothelioma Might You Ask Yourself?

Ask Yourself if You Were Exposed to Asbestos in the Last 50 Years

Malignant Mesothelioma Drug Submission

ONCONASE is being discussed for the treatment of malignant mesothelioma; a pre-NDA meeting is planned in January 2009 to discuss the final components. The actual effectiveness may still be statistically indeterminate, and conditional on a very specific data set regarding patients who failed one prior chemotherapy regimen. The U.S. commercial rights for ONCONASE are leased to to Strativa Pharmaceuticals, a division of Par Pharmaceutical, Inc. from Alfacell Corporation.

$140 million Allocated to Asbestos Claims

Makers of the asbestos-containing Zonolite attic insulation are setting aside 140 million to fund asbestos claims related to Zonolite. Millions of homes use the insulation which is composed of vermiculite ore contaminated with asbestos

Read More

Mesothelioma Court Victory

The Ihe insurance industry's latest attempt to deny compensation to asbestos victims failed as the court ruled that insurers remain liable to pay compensation for mesothelioma, an incurable cancer of the lining of the lung caused by exposure to asbestos at work, if they insured the employer at the time the exposure occurred.

NEW MESOTHELIOMA TREATMENT IN THE WORKS

Imiquimod cream which is usually applied to treat skin cancer, kills advanced mesothelioma tumors in mice. Combined with antiCD40, the combination triggers an immune response.

Read More .